NCT01019395
Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics basic_science 1 completed NCT02134301
Open-Label, Dose-Finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Patients With Suspected or Confirmed Bacterial Infections treatment 1 recruiting NCT00061633
Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI) treatment 2 completed NCT00077675
Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI) treatment 2 completed NCT01446289
Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings No drug interventions prevention 2 completed NCT06592586
A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women No drug interventions prevention 2 / 3 not_yet_recruiting NCT03159403
A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Orbactiv® (Oritavancin) for Infections Caused by Gram Positive Bacteria in a Real World Setting Not Available Not Available completed NCT04847921
Substance Use Disorder (SUD)-Associated Infections' Treatment With Dalbavancin ENabling OUtpatient Transition treatment 2 / 3 terminated NCT00736554
What is the Prevalence of Methicillin-Resistant Staphylococcus Aureus in Skin and Soft Tissue Infections Presenting to the Emergency Departments of a Canadian Academic Health Care Center? No drug interventions Not Available Not Available completed NCT00055198
Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria treatment 3 terminated NCT03747497
Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection treatment 2 completed NCT02750761
A Study of Oral and Intravenous (IV) Tedizolid Phosphate in Hospitalized Participants, Ages 2 to <12 Years, With Confirmed or Suspected Bacterial Infection (MK-1986-013) treatment 1 completed NCT00147511
Time To Efficacy and Onset Of Action Of Linezolid treatment 4 completed NCT00167999
Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units Not Available Not Available completed NCT02013141
Telavancin Pediatric PK Study (Ages >12 Months to 17 Years) basic_science 1 terminated NCT03361163
Controlled Human Infection for Vaccination Against Streptococcus Pyogenes No drug interventions basic_science 1 completed NCT00167960
Study Evaluating Vancomycin-Resistant Enterococci in a Hematology Unit Not Available Not Available completed NCT00081744
Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects treatment 3 completed NCT03560440
Evaluation of the Dosing Regimen of Vancomycin in Pediatric Patients No drug interventions Not Available Not Available completed NCT00035269
New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia) No drug interventions treatment 3 completed NCT03438214
Effect of Intermittent Infusion Versus Continuous Infusion of Vancomycin on Kidney Failure in Critically Ill Patients treatment 4 unknown_status NCT00501150
Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive Infections treatment Not Available completed NCT06444802
Model-informed Precision Dosing for Linezolid treatment 3 not_yet_recruiting NCT00108433
Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections treatment 3 terminated NCT00062647
Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia treatment 2 completed NCT00240747
Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients treatment 3 terminated NCT00406198
Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe Sepsis No drug interventions supportive_care 4 completed NCT00835783
Validation Study of Combined Positron Emission Tomography/Computer Tomography to Diagnose Infection and Inflammation No drug interventions Not Available Not Available terminated NCT03964493
TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection treatment 2 completed NCT05824988
Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung Disease No drug interventions Not Available Not Available recruiting NCT03896685
Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q) treatment 3 active_not_recruiting NCT01212432
Daptomycin Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-venous Hemodiafiltration, a Dose Finding Study treatment 2 unknown_status NCT04911270
Clinical Decision Support Tool for Vancomycin Dosing in Children No drug interventions treatment Not Available active_not_recruiting NCT01564758
Post Marketing Surveillance Study on Linezolid Not Available Not Available completed NCT03982030
Dalbavancin Outpatient Pilot treatment 4 withdrawn NCT00529282
A Study of Ceftobiprole in Patients With Fever and Neutropenia. treatment 3 terminated NCT00079976
Study Evaluating Tigecycline in Selected Serious Infections Caused by Vancomycin-Resistant Enterococcus (VRE) or Methicillin-Resistant Staphylococcus Aureus (MRSA) treatment 3 completed NCT04917380
The Clinical Character，Risk and Prognosis of Post-neurosurgical Intracranial Infection With Different Pathogens. No drug interventions Not Available Not Available unknown_status NCT00136292
Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics Not Available 1 completed NCT00874367
Early-Onset Sepsis Surveillance Study No drug interventions Not Available Not Available completed NCT01412801
Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings No drug interventions prevention 2 completed NCT00037050
Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria treatment 3 completed